Skip to content

Nasdaq · CIK 0000798287

PAMT PAMT CORP

Insider trading from SEC Form 4. Last filing 35 d ago. Close $12.78 on Oct 9, 2026, +70% from the 52-week low and -27% from the high.

PAMT CORP (PAMT) has 9 SEC Form 4 filings on file from 5 insiders, the latest filed on Sep 8, 2026. In the last 90 days insiders made 1 open-market buy worth $31M and 1 open-market sell worth $31M, net $0.

4 open-market trades have been scored at PAMT. The newest: Matthew T Moroun (director and 10% owner) bought $31M of stock on Sep 3, 2026, filed Sep 8, 2026, scored 46 (moderate).

PAMT closed at $12.78 on Oct 9, 2026, 70% above its 52-week low and 27% below its 52-week high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
1
$31M by 1 insider
Sells
1
$31M by 1 insider
Insiders on file
5
with a Form 4 at this company

Price and insider trades, last year

PAMTOct 9, 2026 · close 12.78

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at PAMT CORP, scored.

ScoreInsiderValueHoldingsPrice contextFiled
46ModerateMatthew T Moroun
director, owner
buy
$31M
3,268,000 shares
+26%-
60NotableMatthew T Moroun
director, owner
sell
$31M
3,268,000 shares
-100%-
51ModerateMatthew T Moroun
director, owner
buy
$21M
2,000,000 shares
+19%+14% from low-42% from high
60NotableMatthew T Moroun
director, owner
sell
$21M
2,000,000 shares
-100%+14% from low-42% from high

Transactions

Every row filed, 11 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 3, 2026Matthew T Moroun
director, owner
SOpen-market sale
Common Stock
-3,268,000$9.56$31M035 d ago
Sep 3, 2026Matthew T Moroun
director, owner
POpen-market purchase
Common Stockindirect: By Lindsay S. Moroun Trust
+3,268,000$9.56$31M15,695,84835 d ago
May 8, 2026Michael D. Bishop
director
AGrant or award
Common Stock
+968$10.32$9,9905,156May 12, 2026
Feb 9, 2026Lance Stewart
President and CEO
FTax withholding
Common Stock
-11,354$12.03$137k122,552Feb 11, 2026
Sep 11, 2025Matthew T Moroun
director, owner
SOpen-market sale
Common Stock
-2,000,000$10.75$21M0Sep 15, 2025
Sep 11, 2025Matthew T Moroun
director, owner
POpen-market purchase
Common Stockindirect: By Lindsay S. Moroun Trust
+2,000,000$10.75$21M12,427,848Sep 15, 2025
Aug 4, 2025Lance Stewart
President & CEO
AGrant or award
Common Stock
+100,000$0.00$0133,906Aug 5, 2025
May 12, 2025Michael D. Bishop
director
AGrant or award
Common Stock
+954$15.71$15k4,188May 15, 2025
May 12, 2025Edwin J. Lukas
director
AGrant or award
Common Stock
+954$15.71$15k6,036May 15, 2025
May 12, 2025Matthew T Moroun
director, owner
AGrant or award
Common Stockindirect: By Son
+954$15.71$15k4,558May 15, 2025
May 12, 2025Matthew J. Moroun
director
AGrant or award
Common Stock
+954$15.71$15k4,558May 15, 2025

Insiders

Everyone who has filed a Form 4 here.

Questions about PAMT

Answered from the filings on this page, as of the latest one.

Are insiders buying PAMT?

As of Sep 8, 2026, SEC Form 4 filings show 1 open-market buy worth $31M by 1 insider and 1 open-market sell worth $31M by 1 insider at PAMT CORP in the last 90 days, net $0. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.

Who was the last insider to trade PAMT on the open market?

Matthew T Moroun (director and 10% owner) bought $31M of PAMT on Sep 3, 2026 and filed the Form 4 on Sep 8, 2026. InsiderTell scored 46 (moderate).

How many insiders file Form 4 at PAMT CORP?

5 people have filed a Form 4 at PAMT CORP, among them Michael D. Bishop (director), Edwin J. Lukas (director), Matthew T Moroun (director and 10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.